Skip to main content

Table 4 Reported clinical parameters

From: The association between premorbid beta blocker exposure and mortality in sepsis—a systematic review

First author

Heart rate

Initial blood lactate levels

Peak blood lactate levels

Creatinine levels

Arterial pH

Mean arterial pressure

SOFA score

APACHE II score

APACHE III score

Mechanical ventilation

Vasopressor infusion

Contenti et al.a [21]

100 ± 25 vs 109 ± 25 bpm; p = 0.02

3.9 ± 2.3 mmol/L vs 5.6 ± 3.6 mmol/L; p = 0.0006

72 mmHg ± 22 vs 70 mmHg ± 21; p = 0.48

5.0 ± 2.8 vs 5.3 ± 2.8; p = 0.44

21.0 ± 6.0 vs 21.7 ± 6.9; p = 0.41

15% vs 19%; p = 0.58

31% vs 32%; p = 0.94

Sharma et al.a [25]

3.2 vs 3.6 mmol/L; p = 0.54

94 vs 84; p = 0.14

Cumulative dose 11.4 vs 12.6 mg; p = 0.43

Duration of infusion 1563 vs 1730 min; p = 0.37

de Roquetaillade et al.a [23]

81 (IQR 82–111) vs. 107 (IQR 89–122) bpm; p < 0.01

1.75 (IQR 0.9–3.4) vs. 1.8(IQR 0.8–4) mmol/L; p = 0.97

165.5 (IQR 108–245) vs 135.5 (IQR 82–108); p < 0.00

7.35 (IQR 7.25–7.42) vs 7.34 (IQR 7.23–7.42); p = 0.354

9 (IQR 6–12) vs 9 (IQR 6–13); p = 0.242

81.7% vs 84.9%; p = 0.112

Days on ventilation 4 (IQR 2–9) vs 5.5 (IQR 2–11); p = 0.055

23.2 mg (IQR 5.1–57.0) vs 22.4 mg (IQR 5.2–60.5); p = 0.95

Fuchs et al.b [26]

111 (IQR 97.0–132.8) vs 118 (IQR 97.0–135.5); p = 0.2

2.3 (IQR 1.5–3.8) vs 3.5 (IQR 2.0–6.5); p < 0.01

20.0 (IQR 15.0–24.5) vs 21.0 (IQR 16.2–26.0); p = 0.25

Norepinephrine 91% vs 92.2%; p = 0.83

  1. aPremorbid beta blocker exposure vs no premorbid beta blocker exposure
  2. bContinued beta blocker usage during sepsis vs discontinued beta blocker usage during sepsis